A plural role for lipids in motor neuron diseases: energy, signaling and structure.
about
There's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative DiseasesA lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosisBlood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral SclerosisGene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis.Identification of genes associated with resilience/vulnerability to sleep deprivation and starvation in DrosophilaGene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF.Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.Inhibitor of PI3K/Akt Signaling Pathway Small Molecule Promotes Motor Neuron Differentiation of Human Endometrial Stem Cells Cultured on Electrospun Biocomposite Polycaprolactone/Collagen Scaffolds.Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis.Liver X receptors: from cholesterol regulation to neuroprotection-a new barrier against neurodegeneration in amyotrophic lateral sclerosis?Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.Purmorphamine as a Shh Signaling Activator Small Molecule Promotes Motor Neuron Differentiation of Mesenchymal Stem Cells Cultured on Nanofibrous PCL Scaffold.Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism.Cellular and molecular mechanisms of motor neuron death in amyotrophic lateral sclerosis: a perspective.Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthaseLipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition.Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis.A Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons.Disruption of ER-mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis.Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls.Profile of Arachidonic Acid-Derived Inflammatory Markers and Its Modulation by Nitro-Oleic Acid in an Inherited Model of Amyotrophic Lateral Sclerosis.Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43.Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders.
P2860
Q26768635-011BFDA0-DFBB-4DB0-9826-28EDE8F3EC16Q28384280-A5DED64D-FB6F-4D1E-BAE1-F5ADBC425EE6Q28546154-4BA6ECB5-E9FD-400D-AD68-B8918EA53D61Q30659873-A243ADFB-6A9F-40E2-9B74-A3BB21181EA1Q33899405-51D73F34-255C-469B-ADAB-C6380FD0FC2BQ35478279-A9A823DD-B17E-4C9F-8915-D57E94362A75Q35555633-27561880-3A8A-4D51-AAC0-136E202A1614Q35669383-3BC38561-11B1-47D3-B7C8-1E0ECF96D3B7Q35963342-9CB0ABB7-DA24-4A62-9EE8-83FDC6CC35D6Q38691517-A1A89CEA-1520-44FF-A287-D5AA42ABD5E1Q38760568-89924DB7-37B5-450E-9C5F-832DB23B6012Q38924052-C3086363-A93E-4BE7-B60C-35D06FF3EE27Q38941476-CFA0CCC9-A641-4EDB-A3D8-9A80FAA1103BQ40581202-CF365340-B2CE-4DCF-97F2-19E5412BA6DDQ40814817-A0923780-7EAB-4A3F-A4C0-124744EBAC65Q41585035-8862803F-6122-4BF7-82C8-2CF966145605Q41959651-2751652D-19A3-4303-AA56-08BFFD5BA9AAQ42175283-BA91D007-2C09-4617-AD5F-E5E12EB92B5FQ47908351-05ED981B-AE15-4E02-ABC2-C0950CC88B8BQ49452570-33F45646-F412-4A1C-9925-FBD90A29A4D8Q50072058-B4B79524-4097-4CA5-AC81-C05F0B5C8BC0Q52688982-428FD065-4F96-4EF3-A25D-5AAF23E65BE2Q52721505-2D4DAD68-907B-4646-ABE2-C23110E3CB8FQ54972559-539380BD-41D7-4180-A239-0B8F9C3C5671Q55237897-00527E13-C13D-469F-8C6A-70B88B7DAD7FQ55360003-1F4D0FC4-98CE-4544-8058-95817A4C2A27
P2860
A plural role for lipids in motor neuron diseases: energy, signaling and structure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A plural role for lipids in motor neuron diseases: energy, signaling and structure.
@en
A plural role for lipids in motor neuron diseases: energy, signaling and structure.
@nl
type
label
A plural role for lipids in motor neuron diseases: energy, signaling and structure.
@en
A plural role for lipids in motor neuron diseases: energy, signaling and structure.
@nl
prefLabel
A plural role for lipids in motor neuron diseases: energy, signaling and structure.
@en
A plural role for lipids in motor neuron diseases: energy, signaling and structure.
@nl
P2093
P2860
P356
P1476
A plural role for lipids in motor neuron diseases: energy, signaling and structure.
@en
P2093
Alexandre Henriques
Florent Schmitt
Ghulam Hussain
Jean-Philippe Loeffler
Luc Dupuis
P2860
P356
10.3389/FNCEL.2014.00025
P577
2014-02-20T00:00:00Z